Legislative Activity

The Protect America's Workforce Act nullifies a specific Executive Order issued in March 2025 concerning exclusions from federal labor-management relations programs. This legislation ensures that any existing collective bargaining agreements between federal agencies and employee unions remain fully in effect until their stated expiration dates. The Act also prohibits the use of federal funds to implement the overturned Executive Order.

The ePermit Act mandates the creation of a unified, digital system for managing all federal environmental reviews and project permits. This system will standardize data, automate processes, and provide real-time public access to review status and documents. The goal is to increase transparency, efficiency, and data interoperability across federal agencies involved in project authorizations.

The Adams Memorial-Great American Heroes Act extends the authority of the Adams Memorial Commission until 2032 and approves a specific location for the memorial, allowing it to proceed despite certain location standards. The bill also grants the Commission flexibility to relocate the memorial to the "Reserve" if the primary site proves unsuitable. Finally, it makes technical amendments to existing law to align dates and clarify the memorial's authorization.

This resolution strongly condemns the Iranian government for its ongoing, state-sponsored persecution of the Baha'i religious minority, which violates international human rights laws. It documents systematic abuses, including economic restrictions, denial of education, and arbitrary arrests, noting that these actions may constitute a crime against humanity. The resolution calls on Iran to immediately release all imprisoned Bahais and urges the U.S. President and Secretary of State to condemn these violations and impose sanctions on responsible officials.

The Mikaela Naylon Give Kids a Chance Act focuses primarily on improving pediatric drug development and ensuring patient access to necessary treatments. This legislation mandates new research requirements for molecularly targeted pediatric cancer drugs, strengthens FDA enforcement of pediatric study completion, and extends incentives for developing drugs for rare pediatric diseases. Additionally, the bill updates organ transplant network functions and establishes an Abraham Accords Office within the FDA to enhance international regulatory cooperation.

The AIM Act primarily focuses on eliminating numerous existing statutory restrictions and prohibitions that currently limit the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) in its operations. This includes removing limitations on the use and analysis of firearms trace data and allowing for the consolidation of dealer records. Furthermore, the bill removes requirements for the destruction of background check records and eases restrictions on the ATF's ability to inspect dealer inventories and deny or revoke Federal Firearms Licenses.

The Biomanufacturing Excellence Act of 2025 aims to bolster U.S. leadership in biotechnology by establishing a National Biopharmaceutical Center of Excellence. This Center will accelerate manufacturing innovation, strengthen domestic supply chains, and ensure adherence to quality standards. It will also facilitate crucial workforce training to support the growing biomanufacturing sector.

The Restoring Food Security for American Families and Farmers Act of 2025 aims to strengthen domestic food security by repealing specific sections of a prior reconciliation act. This action effectively revives the original laws that were previously amended by the repealed provisions. The bill seeks to revert existing agricultural and food-related statutes to their pre-amendment status.

This resolution expresses strong support for Gavi, the Vaccine Alliance, recognizing its critical role in saving children's lives through global immunization efforts in low-income countries. It highlights Gavi's proven success in delivering vaccines, strengthening health systems, and providing a significant return on investment. The bill encourages the U.S. to maintain and increase its financial commitment to Gavi to ensure global health security and future vaccine access.

The REPO for Ukrainians Implementation Act of 2025 formally recognizes international calls to repurpose frozen Russian sovereign assets to aid Ukraine. This bill grants the President authority to transfer non-confiscated Russian assets into the Ukraine Support Fund, where they must be invested in U.S. government debt. Furthermore, the Secretary of State is mandated to obligate at least $250 million from the fund to Ukraine every quarter. The Act also requires the President to report on the location of these Russian assets globally and directs diplomatic efforts to encourage allies to contribute quarterly.

The Penicillin Allergy Verification and Evaluation (PAVE) Act addresses the widespread issue of inaccurate penicillin allergy labels, which often lead to poorer patient outcomes. This bill mandates that Medicare cover and require physicians to perform a formal penicillin allergy verification and evaluation for seniors during their initial and annual wellness visits. The goal is to correctly identify patients who can safely take penicillin, improving care and promoting responsible antibiotic stewardship.

This resolution strongly condemns the brutal October 7th attacks by Hamas, demanding the immediate and unconditional surrender of the terrorist group and the release of all hostages, including Americans. It reaffirms Israel's right to self-defense while urging international action against Hamas and condemning the global surge in antisemitism. The measure serves as a formal statement of U.S. policy and support following the attacks.

This bill ensures that states are reimbursed by the Federal Government for any state funds they use to maintain essential operations of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) during a lapse in federal appropriations. It provides a mechanism for the Federal Government to pay back states that cover WIC costs during a government shutdown. This protects state budgets while keeping vital nutrition assistance running.

The Medical Foods and Formulas Access Act of 2025 mandates federal health programs, including Medicare and Medicaid, to cover medically necessary specialized foods and formulas prescribed for managing severe digestive or inherited metabolic disorders. This ensures patients with conditions like urea cycle disorders or short bowel syndrome receive essential, prescribed nutrition when standard food is insufficient. The bill aims to standardize access to these life-sustaining treatments across federal and state health plans.

The Fair Pay for Federal Contractors Act of 2025 ensures that employees of federal contractors are compensated for losses incurred due to government funding lapses or shutdowns. It requires federal agencies to adjust existing contracts to cover reasonable costs associated with furloughs, pay cuts, or mandatory leave taken by contractor employees. The bill appropriates necessary funds to cover these contract price adjustments and mandates public reporting on the compensation provided.

The Baltic Security Assessment Act of 2025 affirms the critical importance of Estonia, Latvia, and Lithuania to U.S. national security amidst Russian aggression. This bill mandates that the Secretary of State and Secretary of Defense deliver a comprehensive report to Congress detailing emerging military, cyber, and political threats to the Baltic states. The report must also recommend specific actions to enhance U.S. and NATO defense cooperation and bolster Baltic resilience.

The Biosimilar Red Tape Elimination Act streamlines the regulatory pathway for biosimilar biological products by making technical and structural updates to existing law. This legislation clarifies when a biosimilar is automatically deemed "interchangeable" with its reference product, protecting existing exclusivity periods. Furthermore, it updates conforming language across federal drug laws and clarifies pediatric testing requirements for biosimilar applications.

This House Resolution strongly condemns all forms of political violence and threats against elected officials and public figures, regardless of political affiliation. It affirms that disagreements must be resolved through peaceful and democratic means, not intimidation or force. The resolution urges law enforcement to prosecute those who commit or encourage such violence. Finally, it calls on all leaders to cease using dehumanizing rhetoric and promote civil discourse.

The Protecting Free Vaccines Act mandates that most private health insurance plans must cover specific vaccines recommended by the CDC's Advisory Committee on Immunization Practices (ACIP) without any out-of-pocket costs until January 1, 2030. This requirement also updates coverage rules for Medicare Part D, Medicaid, and CHIP to ensure continuity of coverage for these recommended immunizations. The bill locks in coverage based on the ACIP recommendations in place as of October 25, 2024, across various federal health programs.

This Act, the Ensuring Patient Access to Critical Breakthrough Products Act, aims to speed up Medicare coverage for innovative, FDA-approved "breakthrough devices." It establishes a process for manufacturers to gain a four-year transitional coverage period for these devices, ensuring patients have timely access while long-term coverage decisions are finalized. The bill also allocates funding to CMS to manage these expedited reviews and allows for oversight of provider billing practices related to these new technologies.